These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8826576

  • 1. Zileuton: a new therapy for asthma or just the first of a new class of drugs.
    Hendeles L, Marshik PL.
    Ann Pharmacother; 1996; 30(7-8):873-5. PubMed ID: 8826576
    [No Abstract] [Full Text] [Related]

  • 2. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE.
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
    Meltzer SS, Hasday JD, Cohn J, Bleecker ER.
    Am J Respir Crit Care Med; 1996 Mar; 153(3):931-5. PubMed ID: 8630575
    [Abstract] [Full Text] [Related]

  • 4. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
    Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling R.
    J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
    [Abstract] [Full Text] [Related]

  • 5. Leukotriene antagonism in asthma and rhinitis.
    Lane SJ.
    Respir Med; 1998 Jun; 92(6):795-809. PubMed ID: 9850362
    [No Abstract] [Full Text] [Related]

  • 6. Preclinical and clinical activity of zileuton and A-78773.
    Bell RL, Lanni C, Malo PE, Brooks DW, Stewart AO, Hansen R, Rubin P, Carter GW.
    Ann N Y Acad Sci; 1993 Nov 30; 696():205-15. PubMed ID: 8109828
    [Abstract] [Full Text] [Related]

  • 7. Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma.
    Wenzel SE, Kamada AK.
    Ann Pharmacother; 1996 Nov 30; 30(7-8):858-64. PubMed ID: 8826571
    [Abstract] [Full Text] [Related]

  • 8. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
    Berger W, De Chandt MT, Cairns CB.
    Int J Clin Pract; 2007 Apr 30; 61(4):663-76. PubMed ID: 17394438
    [Abstract] [Full Text] [Related]

  • 9. Antileukotriene agents and aspirin-sensitive asthma: are we removing the second bassoonist or skating to where the puck is gonna be?
    Lang DM.
    Ann Allergy Asthma Immunol; 2000 Jul 30; 85(1):5-8. PubMed ID: 10923598
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of asthma with antileukotrienes: first line or last resort therapy?
    Dahlén SE.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):40-56. PubMed ID: 16510137
    [Abstract] [Full Text] [Related]

  • 11. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM.
    Am Rev Respir Dis; 1993 Dec 08; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [Abstract] [Full Text] [Related]

  • 12. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
    Dellaripa PF, Wechsler ME, Roth ME, Drazen J.
    Mayo Clin Proc; 2000 Jun 08; 75(6):643-5. PubMed ID: 10852428
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
    Chen X, Wang S, Wu N, Sood S, Wang P, Jin Z, Beer DG, Giordano TJ, Lin Y, Shih WC, Lubet RA, Yang CS.
    Clin Cancer Res; 2004 Oct 01; 10(19):6703-9. PubMed ID: 15475461
    [Abstract] [Full Text] [Related]

  • 14. Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway.
    Drazen JM, Israel E.
    Int Arch Allergy Immunol; 1995 Oct 01; 107(1-3):319-20. PubMed ID: 7613158
    [Abstract] [Full Text] [Related]

  • 15. New approaches to anti-inflammatory therapy for asthma.
    Wenzel SE.
    Am J Med; 1998 Mar 01; 104(3):287-300. PubMed ID: 9552092
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene receptor antagonists: the newest in asthma drugs.
    Stevenson AM.
    MCN Am J Matern Child Nurs; 1997 Mar 01; 22(3):170, 169. PubMed ID: 9145660
    [No Abstract] [Full Text] [Related]

  • 17. [Allergy and leukotrienes].
    Ado VA, Mokronosova MA, Perlamutrov IuN.
    Klin Med (Mosk); 1995 Mar 01; 73(2):9-12. PubMed ID: 7609435
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats.
    Namovic MT, Walsh RE, Goodfellow C, Harris RR, Carter GW, Bell RL.
    Eur J Pharmacol; 1996 Nov 07; 315(1):81-8. PubMed ID: 8960868
    [Abstract] [Full Text] [Related]

  • 19. New directions in asthma drug therapy.
    Drazen JM.
    Hosp Pract (1995); 1998 Feb 15; 33(2):25-6, 31-3, 36-8. PubMed ID: 9484293
    [Abstract] [Full Text] [Related]

  • 20. Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with Dual 5-LO inhibitor and NO-dependent activities.
    Boschi D, Giorgis M, Cena C, Talniya NC, Di Stilo A, Morini G, Coruzzi G, Guaita E, Fruttero R, Gasco A.
    ChemMedChem; 2010 Sep 03; 5(9):1444-9. PubMed ID: 20645382
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.